Abstract
As women will spend approximately three-quarters of their reproductive lifespan avoiding pregnancy, contraception and contraceptive counseling are some of the most important clinical services offered by sexual and reproductive health-care providers. A woman’s long-term goals, personal beliefs, reproductive experience, and medical history can collectively influence her decision to use contraception, as well as her choice of contraceptive method. Given the range of options available to women currently, providing guidance to help tailor a method of contraception to a woman’s needs and preferences is important. This chapter provides guidance on general contraceptive counseling principles, while also providing method-specific guidance.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
ACOG. Long-acting reversible contraception: implants and intrauterine devices. Pract Bull. 2017; 186. https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2017/11/long-acting-reversible-contraception-implants-and-intrauterine-devices
ACOG. Over-the-counter access to hormonal contraception | ACOG. ACOG Committee Opinion; 2019. p. 788. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/10/over-the-counter-access-to-hormonal-contraception
Ali M, Akin A, Bahamondes L, Brache V, Habib N, Landoulsi S, Hubacher D. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant. Hum Reprod. 2016;31(11):2491–8. https://doi.org/10.1093/HUMREP/DEW222.
Allen D, Hunter MS, Wood S, Beeson T. One key question ®: first things first in reproductive health. Matern Child Health J. 2017;21(3):387–92. https://doi.org/10.1007/S10995-017-2283-2.
Audet MC, Moreau M, Koltun WD, Waldbaum AS, Shangold G, Fisher AC, Creasy GW. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial. JAMA. 2001;285(18):2347–54. https://doi.org/10.1001/JAMA.285.18.2347.
Bahamondes L, Faundes A, Sobreira-Lima B, Lui-Filho JF, Pecci P, Matera S. TCu 380A IUD: a reversible permanent contraceptive method in women over 35 years of age. Contraception. 2005;72(5):337–41. https://doi.org/10.1016/J.CONTRACEPTION.2004.12.026.
CDC. U.S. selected practice recommendations for contraceptive use, 2016. Morb Mortal Wkly Rep. 2016a;65(4).
CDC. U.S. selected practice recommendations for contraceptive use, 2016. MMWR Morb Mortal Wkly Rep. 2016b;65(4). internal-pdf://5.36.173.89/2016-CDC-U.S. Selected Practice Recommendation.pdf.
Crosignani PG, Luciano A, Ray A, Bergqvist A. Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. Hum Reprod. 2006;21(1):248–56. https://doi.org/10.1093/HUMREP/DEI290.
Curtis KM. US medical eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep. 2016;65. internal-pdf://0840719407/2016-Curtis-US medical eligibility criteria fo.pdf.
Curtis KM, Mohllajee AP, Peterson HB. Regret following female sterilization at a young age: a systematic review. Contraception. 2006;73(2):205–10. https://doi.org/10.1016/J.CONTRACEPTION.2005.08.006.
Dehlendorf C, Grumbach K, Schmittdiel JA, Steinauer J. Shared decision making in contraceptive counseling. Contraception. 2017. https://doi.org/10.1016/j.contraception.2016.12.010.
Depot Medroxyprogesterone Acetate Use and the Development an…: Obstet Gynecol. (n.d.). Retrieved April 17, 2022, from https://journals.lww.com/greenjournal/Fulltext/9900/Depot_Medroxyprogesterone_Acetate_Use_and_the.437.aspx
Dragoman MV, Simmons KB, Paulen ME, Curtis KM. Combined hormonal contraceptive (CHC) use among obese women and contraceptive effectiveness: a systematic review. Contraception. 2017;95(2):117–29. https://doi.org/10.1016/J.CONTRACEPTION.2016.10.010.
Glasier AF, Cameron ST, Fine PM, Logan SJ, Casale W, Van Horn J, Sogor L, Blithe DL, Scherrer B, Mathe H, Jaspart A, Ulmann A, Gainer E. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet. 2010;375(9714):555–62. https://doi.org/10.1016/S0140-6736(10)60101-8.
Goldthwaite LM, Shaw KA. Immediate postpartum provision of long-acting reversible contraception. Curr Opin Obstet Gynecol. 2015;27(6):460–4. https://doi.org/10.1097/GCO.0000000000000224.
Grimes DA, Schulz KF. Nonspecific side effects of oral contraceptives: nocebo or noise? Contraception. 2011;83(1):5–9. https://doi.org/10.1016/J.CONTRACEPTION.2010.06.010.
Harel Z, Johnson CC, Gold MA, Cromer B, Peterson E, Burkman R, Stager M, Brown R, Bruner A, Coupey S, Hertweck P, Bone H, Wolter K, Nelson A, Marshall S, Bachrach LK. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections. Contraception. 2010;81(4):281–91. https://doi.org/10.1016/j.contraception.2009.11.003.
Havrilesky LJ, Gierisch JM, Moorman PG, Coeytaux RR, Urrutia RP, Lowery WJ, Dinan M, McBroom AJ, Wing L, Musty MD, Lallinger KR, Hasselblad V, Sanders GD, Myers ER. Oral contraceptive use for the primary prevention of ovarian cancer. Evid Rep Technol Assess (Full Rep). 2013;(212):1–514.
Herrel LA, Goodman M, Goldstein M, Hsiao W. Outcomes of microsurgical vasovasostomy for vasectomy reversal: a meta-analysis and systematic review. Urology. 2015;85(4):819–25. https://doi.org/10.1016/J.UROLOGY.2014.12.023.
Kathawa CA, Arora KS. Implicit bias in counseling for permanent contraception: historical context and recommendations for counseling. Health Equity. 2020;4(1):326–9. https://doi.org/10.1089/HEQ.2020.0025.
Killick SR, Leary C, Trussell J, Guthrie KA. Sperm content of pre-ejaculatory fluid. Hum Fertil (Camb). 2011;14(1):48–52. https://doi.org/10.3109/14647273.2010.520798.
Kim SH, Moon SY, Shin CJ, Lee JY, Kim JG, Chang YS. Microsurgical reversal of tubal sterilization: a report on 1,118 cases. Fertil Steril. 1997;68(5):865–70. https://doi.org/10.1016/S0015-0282(97)00361-0.
Le YCL, Rahman M, Berenson AB. Early weight gain predicting later weight gain among depot medroxyprogesterone acetate users. Obstet Gynecol. 2009;114(2 Pt 1):279. https://doi.org/10.1097/AOG.0B013E3181AF68B2.
Lidegaard O, Nielsen LH, Skovlund CW, Løkkegaard E. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001–10. BMJ. 2012;344 https://doi.org/10.1136/BMJ.E2990.
Lopez LM, Grimes DA, Schulz KF, Curtis KM, Chen M. Steroidal contraceptives: effect on bone fractures in women. Cochrane Database Syst Rev. 2014;(6):CD006033. https://doi.org/10.1002/14651858.CD006033.pub5.
Nelson AL, Kaunitz AM, Kroll R, Simon JA, Poindexter AN, Castaño PM, Ackerman RT, Flood L, Chiodo JA, Garner EI. Efficacy, safety, and tolerability of a levonorgestrel/ethinyl estradiol transdermal delivery system: phase 3 clinical trial results. Contraception. 2020;103(3):137–43. https://doi.org/10.1016/j.contraception.2020.11.011.
Nguyen BT, Nelson AL. Time for the US food and drug administration approval of condoms for anal intercourse. EClinicalMedicine. 2019;17:100226. https://doi.org/10.1016/j.eclinm.2019.11.019.
Nguyen BT, Jochim AL, Shih GH. Offering the full range of contraceptive options: a survey of interest in vasectomy training in the US family planning community. Contraception. 2017;95(5):500–4. https://doi.org/10.1016/j.contraception.2017.01.002.
Pardthaisong T. Return of fertility after use of the injectable contraceptive Depo Provera: up-dated data analysis. J Biosoc Sci. 1984;16(1):23–34. https://doi.org/10.1017/S0021932000014760.
Pearson JT, Chelstowska M, Rowland SP, Benhar E, Kopp-Kallner H, Berglund Scherwitzl E, Acuna J, Gemzell Danielsson K, Scherwitzl R. Contraceptive effectiveness of an FDA-cleared birth control app: results from the natural cycles U.S. Cohort. J Women’s Health. 2021;30(6):782–8. https://doi.org/10.1089/JWH.2020.8547/SUPPL_FILE/SUPP_TABLES1.DOCX.
Reed S, Do Minh T, Lange JA, Koro C, Fox M, Heinemann K. Real world data on Nexplanon® procedure-related events: final results from the Nexplanon Observational Risk Assessment study (NORA). Contraception. 2019;100(1):31–6. https://doi.org/10.1016/J.CONTRACEPTION.2019.03.052.
Rowe PJ, Boccard S, Farley TMM, Peregoudov S, Reinprayoon D, Koetsawang S, Shangchun W, Gopalan S, Xiem NT, De La Concepcion O, Andolsek-Jeras L, Sikazwe NC, Ramos RM, Fabella J, Dubnitskaya L, Pizarro E, Grimon RU, Cardet EC, Liu-Qi Z, et al. Long-term reversible contraception: twelve years of experience with the TCu380A and TCu220C. Contraception. 1997;56(6):341–52. https://doi.org/10.1016/S0010-7824(97)00186-8.
Schwallie PC, Assenzo JR. The effect of depo-medroxyprogesterone acetate on pituitary and ovarian function, and the return of fertility following its discontinuation: a review. Contraception. 1974;10(2):181–202. https://doi.org/10.1016/0010-7824(74)90073-0.
Schwartz JL, Weiner DH, Lai JJ, Frezieres RG, Creinin MD, Archer DF, Bradley L, Barnhart KT, Poindexter A, Kilbourne-Brook M, Callahan MM, Mauck CK. Contraceptive efficacy, safety, fit, and acceptability of a single-size diaphragm developed with end-user input. Obstet Gynecol. 2015;125(4):895–903. https://doi.org/10.1097/AOG.0000000000000721.
Secura GM, Allsworth JE, Madden T, Mullersman JL, Peipert JF. The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception. Am J Obstet Gynecol. 2010;203(2):115.e1–7. https://doi.org/10.1016/j.ajog.2010.04.017.
Sharlip ID, Belker AM, Honig S, Labrecque M, Marmar JL, Ross LS, Sandlow JI, Sokal DC. Vasectomy: AUA guideline. J Urol. 2012;188(6 Suppl):2482–91. https://doi.org/10.1016/j.juro.2012.09.080.
Simmons RG, Sanders JN, Geist C, Gawron L, Myers K, Turok DK. Predictors of contraceptive switching and discontinuation within the first 6 months of use among Highly Effective Reversible Contraceptive Initiative Salt Lake study participants. Am J Obstet Gynecol. 2019;220(4):376.e1. https://doi.org/10.1016/J.AJOG.2018.12.022.
Statement from FDA Commissioner Scott Gottlieb, M.D., on manufacturer announcement to halt Essure sales in the U.S.; agency’s continued commitment to postmarket review of Essure and keeping women informed | FDA. n.d. Retrieved March 15, 2021, from https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-manufacturer-announcement-halt-essure-sales-us-agencys
Thomas MA, Chappell BT, Maximos B, Culwell KR, Dart C, Howard B. A novel vaginal pH regulator: results from the phase 3 AMPOWER contraception clinical trial. Contracept X. 2020;2:100031. https://doi.org/10.1016/j.conx.2020.100031.
Trussell J, Vaughan B. Contraceptive failure, method-related discontinuation and resumption of use: results from the 1995 National Survey of Family Growth. Perspect Sex Reprod Health. 1999;31(2):64–72. https://www.guttmacher.org/journals/psrh/1999/03/contraceptive-failure-method-related-discontinuation-and-resumption-use
Turok DK, Gero A, Simmons RG, Kaiser JE, Stoddard GJ, Sexsmith CD, Gawron LM, Sanders JN. Levonorgestrel vs. copper intrauterine devices for emergency contraception. N Engl J Med. 2021;384(4):335–44. https://doi.org/10.1056/NEJMOA2022141/SUPPL_FILE/NEJMOA2022141_DATA-SHARING.PDF.
Van Damme L, Ramjee G, Alary M, Vuylsteke B, Chandeying V, Rees H, Sirivongrangson P, Mukenge-Tshibaka L, Ettiègne-Traoré V, Uaheowitchai C, Karim SS, Mâsse B, Perriëns J, Laga M; COL-1492 Study Group. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet. 2002;360(9338):971–7. https://doi.org/10.1016/s0140-6736(02)11079-8.
Walter JR, Ghobadi CW, Hayman E, Xu S. Hysteroscopic sterilization with essure. Obstet Gynecol. 2017;129(1):10–9. https://doi.org/10.1097/AOG.0000000000001796.
Zheng SR, Zheng HM, Qian SZ, Sang GW, Kaper RF. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon®) and a six-capsule (Norplant®) hormonal contraceptive implant 1. Contraception. 1999;60(1):1–8. https://doi.org/10.1016/S0010-7824(99)00053-0.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 This is a U.S. Government work and not under copyright protection in the U.S.; foreign copyright protection may apply
About this entry
Cite this entry
Myo, M., Heyrana, K.J., Nguyen, B.T. (2023). Contraception. In: Shoupe, D. (eds) Handbook of Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-031-14881-1_17
Download citation
DOI: https://doi.org/10.1007/978-3-031-14881-1_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-14880-4
Online ISBN: 978-3-031-14881-1
eBook Packages: MedicineReference Module Medicine